Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.67 |
| ▸ | CA1 | P00915 | 4/20 | 0.67 |
| ▸ | CA2 | P00918 | 4/20 | 0.67 |
| ▸ | CA7 | P43166 | 4/20 | 0.67 |
| ▸ | CA9 | Q16790 | 4/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | PKM | P14618 | 2/20 | 0.67 |
| ▸ | CA3 | P07451 | 1/20 | 0.67 |
| ▸ | CA4 | P22748 | 1/20 | 0.67 |
| ▸ | CA6 | P23280 | 1/20 | 0.67 |
| ▸ | CA5A | P35218 | 1/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | XDH | P47989 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | GFER | P55789 | 1/20 | 0.63 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1465618 | 0.92 | KDM4E (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30594704 | 0.92 | KDM4E (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17655667 | 0.90 | KDM4E (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9145572 | 0.88 | KDM4E (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL402146 | 0.88 | KDM4E (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL401597 | 0.88 | LMNA (0.53) | CA12CA1CA2CA7CA9 | |
| Syringate SCHEMBL27447759 | 0.88 | ABCC1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28512343 | 0.87 | PKM (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL751242 | 0.87 | KDM4E (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17894021 | 0.87 | LMNA (0.58) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 905 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122032340-A | Oil-water separation membrane with dye adsorption and pH response functions as well as preparation method and application thereof | 嘉兴大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | claimed |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| WO-2025096261-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025049141-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-03-06 | — | — | WO | claimed |
| CN-119490645-A | Preparation and application of biodegradable polyester based on methyl syringate derivative | 武汉科技大学 | 2025-02-21 | — | — | CN | claimed |
| EP-2514017-A1 | A MULTILAYERED STRUCTURE | Teknologian Tutkimuskeskus VTT (FI) | 2012-10-24 | — | — | EP | claimed |
| WO-2012055010-A1 | MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2012-05-03 | — | — | WO | claimed |
| US-20110308790-A1 | IN SITU METHANOGENESIS MODELING AND RISK ANALYSIS | CONOCOPHILLIPS COMPANY (US) | 2011-12-22 | — | — | US | claimed |
| WO-2011159919-A2 | IN SITU METHANOGENESIS MODELING AND RISK ANALYSIS | CONOCOPHILLIPS COMPANY (US) | 2011-12-22 | — | — | WO | claimed |
| WO-2011073530-A1 | A MULTILAYERED STRUCTURE | TEKNOLOGIAN TUTKIMUSKESKUS VTT (FI) | 2011-06-23 | — | — | WO | claimed |
| US-20090280408-A1 | NOVEL THIN FILM STRUCTURES | VOLTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2009-11-12 | — | — | US | claimed |
| EP-2036151-A2 | NOVEL THIN FILM STRUCTURES | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-03-18 | — | — | EP | claimed |
| WO-2007147947-A2 | NOVEL THIN FILM STRUCTURES | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-27 | — | — | WO | claimed |
| US-5383050-A | Optical waveguide device | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-01-17 | — | — | US | claimed |
| EP-0239423-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-09-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | CA12 1192/4885CA1 929/4885CA2 1872/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CA12 2506/4885CA1 2080/4885CA2 1663/4885 |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CA12 2506/4885CA1 2080/4885CA2 1663/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | CA12 1484/4885CA1 1222/4885CA2 2609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.